Methodical approaches to collecting and analyzing the exhaled breath condensate by Avramenko, Y. M. et al.
                                                                                                                 Проблеми екології та медицини 
 59 
ENGLISH VERSION: METHODICAL APPROACHES TO COLLECTING AND 
ANALYZING THE EXHALED BREATH CONDENSATE* 
Ya.M. Avramenko, O.A. Borzykh 
Higher State Educational Establishment of Ukraine «Ukrainian Medical Stomatological Academy» 
Currently, one of the promising non-invasive diagnostic methods in pulmonology, cardiology, endocrinology, oncology is 
the study of the exhaled breath condensate (EBC). A significant limitation of the study of EBC in clinical practice is the 
absence of generally accepted standards for its collection and study of the content of biological substances containing 
ultra low concentrations in it. The growing scientific and practical interest in this issue led to the organization of the tar-
get group American Thoracic Society and the European Respiratory Society and the development of recommendations 
for the collection of condensate. We have studied and analyzed the recommendations of ATS / ERS and developed an 
algorithm for sampling EBC. 
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Non-invasive diagnostics is one of the important di-
rections in modern medicine. The relevance of the prob-
lem is due to the impact minimization methods of collect-
ing the material for analysis, when a patient does not 
have to experience pain, physical and emotional discom-
fort. It is also due to the safety of the study because it ex-
cludes the possibility to contract blood-borne or tool-
borne infections. Non-invasive diagnostic methods can 
be used, on the one hand, in outpatient settings, which 
ensures their widespread use; on the other hand - in pa-
tients at the intensive care unit, because the severity of 
patient's condition is not a contraindication for their con-
ducting. Currently, the study of exhaled breath conden-
sate (EBC) is one of the promising non-invasive methods 
in pulmonology, cardiology, endocrinology and oncology. 
EBC contains numerous components, the main of which 
is exhaled condensed liquid: it constitutes 99% of the 
volume of EBC. Only a small fraction of it contains non-
volatile molecules that can be hydrophilic and hydropho-
bic. During condensation, volatile, water-soluble particles 
are adsorbed along with the liquid. EBC does not contain 
cells, but there are many different biologically active sub-
stances that are produced by the cellular elements of the 
airway mucosa, which has already been substantiated 
[1], [2], [3]. 
A significant limitation of EBC study in clinical practice 
is the absence of generally accepted standards for its 
collection and examination of its content of biological 
substances, which contain ultra-low concentrations. 
The main ways to solve the problem are standardiza-
tion and development of unified approaches to the collec-
tion and analysis of EBC. On resolving these major is-
sues, we will obtain more evidence and effectiveness in 
the application of this diagnostic method. A burst of sci-
entific and practical interest to this issue led to organiza-
tion of the target group of the American Thoracic Society 
and the European Respiratory Society in 2001, with the 
aim of development of recommendations for condensate 
collecting, which were published in 2005 [1] with revi-
sions and amendments in 2012 [3] and 2013 [4]. At this 
stage, the existing problems are solved by following the 
ATS/ERS recommendations in EBC: 
- standardization of terminology; 
- studying the composition of EBC; 
- description of the procedure for condensate collect-
ing. 
The result of implementing the ATS/ERS recommen-
dations is the further development in this direction of non-
invasive diagnostics of diseases: 
- serial production of special condensate collection 
devices such as EcoScreen® (Jaeger Tonnies 
Hoechberg, Germany); R-Tube® (Respiratory Research, 
Inc., USA), and accessories - mouthpieces, saliva collect-
ing frame, nasal clamps, and others. 
- the commonly accepted conditions for carrying out 
the procedure of collecting EBC have been formulated: 
the time of condensate collecting, the duration of the pro-
cedure, the amount of condensate, the temperature of 
cooling during the collection of condensate and the tem-
perature for storage of samples, the intensity of exhala-
tion, the maneuver of exhalation, control of contamination 
with saliva, body position during the procedure, preparing 
the patient for the procedure (rinsing the mouth, absti-
nence from food and smoking). 
- new substrates have been isolated in EBC: inter-
leukins, cytokines, chemokines, eicosanoids, erythropoi-
etin, adenosine, DNA and others. 
Analyzing the modern recommendations, we devel-
oped the algorithm of the procedure for EBC collecting. 
Specifications:  
1. In order to collect EBC, it is permissible to use 
commercial devices or self-made products. The best way 
to carry out the procedure is to use commercial models of 
condensers, since this allows us to avoid many problems. 
Commercial models such as EcoScreen®, Jaeger, Ana-
con have an unidirectional valve that prevents accidental 
cooling of the air from the condenser during inhalation, 
which is important for preventing mixing of air. R-Tube® 
is individual, it does not need to be disinfected. They ex-
clude the possibility of the release of detergent residue 
into EBC, which also affects the composition of conden-
sate. The device must have a salivary collecting frame 
with a mouthpiece, as it is important to control continu-
ously the contamination of the EBC with saliva, as it has 
already been proven that contamination with saliva may 
affect the level of various mediators in EBC. At the same 
time, the use of filter is not recommended because it can 
become a trap for molecules contained in exhaled air. As 
a cooling component, one can use ice, ethanol, liquid ni-
trogen, and frozen metal tubes. 
In the case of using a self-made device, it is neces-
sary to specify the detailed information about the appli-
ance (saliva collecting frame, its resistance, material of 
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the condensation surface, cooling method, condenser 
temperature, and their stability during the assembly pe-
riod). 
The device is assembled before the procedure be-
gins. 
2. Preparing the patient for the procedure:  
- The study should be conducted in the morning 
(8.00-12.00), on an empty stomach or at least 8 hours 
after a light breakfast. When re-examining on another 
day, it is preferable to conduct the study at the same time 
of day. 
- The patient must not smoke and drink alcohol within 
24 hours [6]. 
- The patient must not take medications 12 hours be-
fore the procedure. 
- Before launching the study, it is necessary to com-
prehensibly explain the patient the method of conducting, 
to instruct the patient, and in case of need (for children, 
elderly patients) to demonstrate the procedure, paying 
attention to the intensity, duration of exhalation, periods 
of rest, control of contamination with saliva). 
- It is necessary to carry out the study at rest, at least 
30 minutes after physical exertion. Before study, the pa-
tient must rest for 10-15 minutes. 
- One should conduct research in clothing that does 
not compress the thorax and the upper respiratory tract. 
It is required to remove any foreign objects (dentures, 
chewing gum, etc.) from the oral cavity. 
- The patient is offered to carefully remove the traces 
of possible contamination (saliva, cosmetics, food re-
mains) from the area of lips with a gauze cloth dipped in 
distilled water, and then is asked to rinse the mouth for 
three times with warm boiled water. 
3. Condensate collection:  
- Put the patient in a comfortable sitting position, in 
the calm atmosphere, with the feeling of maximum com-
fort. 
- Conduct the study with the use of a nasal clamp dur-
ing exhalation, the clamp is removed by the patient at 
each inhalation through the nose. 
- During the study, the patient must tightly hold a 
mouthpiece with his/her lips, but must not close the 
mouthpiece with the tongue or teeth during exhalation. 
- On the average, 10–15 minutes are required to col-
lect 1-2 ml of condensate, under condition of the correct, 
regular, not too slow exhalation through the mouth, inha-
lation only through the nose, without exhausting a pa-
tient. When collecting condensate, the flow of exhaled air 
is always streamed directly to the chilled chamber where 
it is collected in the form of condensate. 
- If necessary, a re-examination can be done after a 
rest in 30 minutes or postponed to another day. * 
4. Storage and analysis of condensate  
- Samples of CVD should be frozen immediately after 
collection and stored at -70°C until the analyzes. If it is 
planned to measure more than one marker, samples 
should be collected in different test tubes, in order to 
avoid further freezing / defrost cycles that can destroy 
biological substances. 
- Most mediators that are detected in EBC are con-
tained in ultra-low concentrations, and the measured val-
ues have a high variability. The potential solution to this 
problem is concentration of samples, which allows us to 
increase the sensitivity and reproducibility of the method. 
For this purpose, lyophilization, resuspension and vac-
uum evaporation may be used, depending on the nature 
of the biomarkers to be studied. 
Note * There are currently no studies showing the effect of respi-
ratory depression, the effect of cough (both random 
and induced) during the procedure on the concentra-
tion of biomarkers in EBC. The volume of EBC does 
not depend on the functional parameters of the lungs, 
including the forced expiratory volume in 1 second 
(FEV1) and forced vital capacity of the lungs (FVCL) 
in healthy subjects and patients with broncho-
obstructive disease. There is currently no data indi-
cating a change in the concentration of markers in 
EBC when changing the airway gauge, there is no 
data on the potential impact of race, gender and body 
position during the collection of EBC. ̽ 
Conclusions 
1. Currently, due to the lack of national recommenda-
tions for the EBC in Ukraine, it is necessary to follow the 
ATS / ERS recommendations [1]. 
2. Applying the above-mentioned algorithm, devel-
oped on the basis of the ATS / ERS recommendations, 
one can significantly enhance the implementation of this 
method for study in different fields of medicine and stan-
dardization of biomarkers analysis. 
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